 | Up a level |
Journal Article
Balermpas, P., Martin, D., Wieland, U., Rave-Fraenk, M., Strebhardt, K., Roedel, C., Fokas, E. and Roedel, F. (2017). Human Papilloma Virus-Load and PD-1/PD-L1, CD8 and FOXP3 in radiochemotherapy Patients with Anal Cancer: Rationale for Immunotherapy. Strahlenther. Onkol., 193. S. S32 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Martin, D., Balermpas, P., Winkelmann, R., Wieland, U., Rave-Fraenk, M., Helmke, C., Raab, M., Kitz, J., Matthess, Y., Strebhardt, K., Roedel, C., Roedel, F. and Fokas, E. (2018). Assessing the immune contexture of anal squamous cell carcinoma. Radiother. Oncol., 127. S. S75 - 2. CLARE: ELSEVIER IRELAND LTD. ISSN 1879-0887
Roedel, F., Wieland, U., Fraunholz, I, Kitz, J., Rave-Fraenk, M., Wolff, H., Weiss, C., Wirtz, R., Balermpas, P., Fokas, E. and Roedel, C. (2014). HPV-16 viral load and p16(INK4a) expression as a predictive marker for tumor control and survival after definitive chemoradiotherapy for patients with anal carcinoma. Strahlenther. Onkol., 190. S. 20 - 21. MUNICH: URBAN & VOGEL. ISSN 1439-099X